NeoAg Summit

Memo

The NeoAg Summit is the only industry-dedicated meeting focused on the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies. Neoantigen-targeted therapies are fast becoming the hottest area in personalized immunotherapies. With significant breakthroughs in technology, join us as we optimize the discovery and prediction of neoantigens, accelerating the industry to advance into clinic and effectively target tumor indications. At the NeoAg Summit, we bring together the leading pharma and biotech companies to discuss:- Advance neoantigen prediction approaches- Improve immunogenicity and learn combination strategies- Scale manufacture to improve the commercial potential of personalized therapies Join the leaders from Genocea, Gritstone, Neon Therapeutics, Ziopharm Oncology, Parker Institute for Cancer Immunotherapy, La Jolla Institute for Allergy and Immunology and many more to spur on more efficacious personalised cancer vaccines and cell therapies. https://neo-antigen.com/ November 20-22, 2019 Contact:This email address is being protected from spambots. You need JavaScript enabled to view it.+1 617 455 4188 URLs:Brochure: https://go.evvnt.com/479903-0?pid=5569Tickets: https://go.evvnt.com/479903-1?pid=5569 Date and Time: On Wednesday November 20, 2019 at 8:00 am (ends Friday November 22, 2019 at 4:00 pm) Venue Details: The Colonnade Hotel, 120 Huntington Avenue, Boston, 02116, United States